The Oncology Institute Inc (TOI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 502,729 | 393,412 | 324,239 | 252,483 | 203,003 |
| Cost of Goods | 426,294 | 339,415 | 264,666 | 200,390 | 162,155 |
| Gross Profit | 76,435 | 53,997 | 59,573 | 52,093 | 40,848 |
| Operating Expenses | 112,812 | 114,530 | 137,257 | 134,434 | 86,861 |
| Operating Income | -36,083 | -60,118 | -77,018 | -81,951 | -45,858 |
| Interest Expense | 11,276 | 7,496 | 6,777 | 4,082 | 320 |
| Other Income | -13,378 | 2,951 | 691 | 85,942 | 34,580 |
| Pre-tax Income | -60,737 | -64,663 | -83,104 | -91 | -11,598 |
| Income Tax | -131 | N/A | -36 | -243 | -671 |
| Net Income Continuous | -60,606 | -64,663 | -83,068 | 152 | -10,927 |
| Net Income | $-60,606 | $-64,663 | $-83,068 | $152 | $-10,927 |
| EPS Basic Total Ops | -0.54 | -0.71 | -0.92 | 0.00 | -0.16 |
| EPS Basic Continuous Ops | -0.66 | -0.86 | -1.13 | 0.00 | -0.17 |
| EPS Diluted Total Ops | -0.54 | -0.71 | -0.92 | -0.21 | -0.16 |
| EPS Diluted Continuous Ops | -0.66 | -0.86 | -1.13 | 0.00 | -0.17 |
| EPS Diluted Before Non-Recurring Items | -0.54 | -0.71 | -0.69 | -0.40 | 0.25 |
| EBITDA(a) | $-20,759 | $-48,026 | $-50,704 | $-66,172 | $-42,464 |